Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial.
Sinn M, Bahra M, Liersch T, Gellert K, Messmann H, Bechstein W, Waldschmidt D, Jacobasch L, Wilhelm M, Rau BM, Grützmann R, Weinmann A, Maschmeyer G, Pelzer U, Stieler JM, Striefler JK, Ghadimi M, Bischoff S, Dörken B, Oettle H, Riess H. Sinn M, et al. Among authors: grutzmann r. J Clin Oncol. 2017 Oct 10;35(29):3330-3337. doi: 10.1200/JCO.2017.72.6463. Epub 2017 Aug 17. J Clin Oncol. 2017. PMID: 28817370 Clinical Trial.
Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma.
Riener MO, Pilarsky C, Gerhardt J, Grützmann R, Fritzsche FR, Bahra M, Weichert W, Kristiansen G. Riener MO, et al. Among authors: grutzmann r. Histol Histopathol. 2009 Sep;24(9):1121-8. doi: 10.14670/HH-24.1121. Histol Histopathol. 2009. PMID: 19609859
Evaluation of POSSUM for patients undergoing pancreatoduodenectomy.
Rückert F, Kuhn M, Scharm R, Endig H, Kersting S, Klein F, Bahra M, Rückert W, Wilhelm TJ, Niedergethmann M, Grützmann R. Rückert F, et al. Among authors: grutzmann r. J Invest Surg. 2014 Dec;27(6):338-48. doi: 10.3109/08941939.2014.932475. Epub 2014 Jul 16. J Invest Surg. 2014. PMID: 25029109
Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.
Petrova E, Rückert F, Zach S, Shen Y, Weitz J, Grützmann R, Wittel UA, Makowiec F, Hopt UT, Bronsert P, Kühn F, Rau BM, Izrailov RE, Khatkov IE, Lapshyn H, Bolm L, Bausch D, Keck T, Wellner UF, Seifert G. Petrova E, et al. Among authors: grutzmann r. Langenbecks Arch Surg. 2017 Aug;402(5):831-840. doi: 10.1007/s00423-017-1590-9. Epub 2017 Jun 13. Langenbecks Arch Surg. 2017. PMID: 28612115
[R1 resection for pancreatic carcinoma].
Weber GF, Kersting S, Haller F, Grützmann R. Weber GF, et al. Among authors: grutzmann r. Chirurg. 2017 Sep;88(9):764-770. doi: 10.1007/s00104-017-0462-8. Chirurg. 2017. PMID: 28653152 Review. German.
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial.
Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, Ströbel P, Grabenbauer GG, Graeven U, Hofheinz RD, Köhne CH, Wittekind C, Sauer R, Kaufmann M, Hothorn T, Rödel C; German Rectal Cancer Study Group. Fokas E, et al. Among authors: grutzmann r. Ann Oncol. 2018 Jul 1;29(7):1521-1527. doi: 10.1093/annonc/mdy143. Ann Oncol. 2018. PMID: 29718095 Free article. Clinical Trial.
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.
Diefenhardt M, Hofheinz RD, Martin D, Beißbarth T, Arnold D, Hartmann A, von der Grün J, Grützmann R, Liersch T, Ströbel P, Grabenbauer GG, Rieger M, Fietkau R, Graeven U, Weitz J, Folprecht G, Ghadimi M, Rödel F, Rödel C, Fokas E; German Rectal Cancer Study Group. Diefenhardt M, et al. Among authors: grutzmann r. Int J Cancer. 2019 Oct 15;145(8):2282-2291. doi: 10.1002/ijc.32274. Epub 2019 Apr 2. Int J Cancer. 2019. PMID: 30868576 Free article. Clinical Trial.
377 results